Video Latest - ecancer

Highlights in early non-metastatic NSCLC and thoracic tumours

Dr Enriqueta Felip - Vall d'Hebron University Hospital (VHIO), Barcelona, Spain

26 Oct 2018

Anti–PD-L1 atezolizumab or chemotherapy as second-line therapy in patients with SCLC

Prof Jean-Louis Pujol - CHRU de Montpellier, Hôpital Arnaud de Villeneuve, Montpellier, France

26 Oct 2018

Combination strategies of immunotherapy in breast cancer

Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy

26 Oct 2018

Highlights in SCLC from ESMO 2018

Dr Noemi Reguart - University of Barcelona, Barcelona, Spain

26 Oct 2018

ABOUND.sqm: nab-paclitaxel and carboplatin induction followed by nab-paclitaxel maintenance in NSCLC

Dr David R. Spigel - Tennessee Oncology, Nashville, USA

26 Oct 2018

Safety analysis of entrectinib for NTRK fusion tumours

Dr George D. Demetri - Harvard Cancer Center, Boston, USA

26 Oct 2018

TRITON2: Evaluation of rucaparib in patients with metastatic castration-resistant prostate cancer

Dr Josep Piulats - IDIBELL, Barcelona, Spain

26 Oct 2018

ASCEND-8: safety data of ceritinib with or without food in NSCLC

Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, Republic of Korea

26 Oct 2018

CheckMate142: Checkpoint combination therapy in first-line colorectal cancer

Dr Heinz-Josef J. Lenz - Keck School of Medicine of USC, Los Angeles, USA

26 Oct 2018

SOLO1: Maintenance olaparib in advanced BRCA ovarian cancer

Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA

26 Oct 2018

Lung highlights from ESMO 2018

Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy

26 Oct 2018

Erlotinib for neoadjuvant treatment of EGFR NSCLC

Dr Wen-Zhao Zhong - Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

26 Oct 2018

Video